Drug Type Synthetic peptide |
Synonyms Long Lasting Glucagon (AmideBio), Solution Stable Glucagon (AmideBio), Solution stable glucagon analog (AmideBio) |
Target |
Mechanism GCGR agonists(Glucagon receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Congenital Hyperinsulinism | Preclinical | US | 17 Jun 2024 |